Innate Pharma S.A. (EPA:IPH)
1.804
+0.086 (5.01%)
Apr 23, 2025, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €151.20 million as of April 23, 2025. Its market cap has decreased by -19.90% in one year.
Market Cap
151.20M
Enterprise Value
101.42M
Revenue
20.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.80
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 151.20M, an increase of 18,987.56%. That is a compound annual growth rate of 32.86%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EssilorLuxottica Société anonyme | 112.94B |
Sanofi | 111.03B |
Sartorius Stedim Biotech | 18.21B |
bioMérieux | 13.41B |
Eurofins Scientific SE | 9.03B |
Ipsen | 7.46B |
Virbac | 2.53B |
emeis Société anonyme | 1.87B |